Press Releases

Ra Medical to Hold 2018 Fourth Quarter and Full Year Conference Call on March 14, 2019

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2018 fourth quarter and full year financial results after market close on Thursday, March 14, 2019. Ra Medical management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.

Live Call:   U.S.   866-789-3291
International 409-937-8946
Passcode 1696453
 
Live Webcast:

Ra Medical Website

The webcast will be archived for 30 days.
 
Replay: U.S. 855-859-2056
International 404-537-3406
Passcode 1696453
The replay will be available for 48 hours
 

About Ra Medical Systems

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017, the DABRA laser system and disposable DABRA catheter received FDA 510(k) clearance in the U.S. for the intended use of ablating a channel in occlusive peripheral vascular disease. Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. DABRA and Pharos are both based on Ra Medical’s core excimer laser technology platform and deploy similar mechanisms of action. Independent in vivo and in vitro research studies have demonstrated that 308 nanometer excimer laser light, which is the same wavelength used in DABRA and Pharos, increases T-cell apoptosis, or cell death, which may produce an immunosuppressive effect. Ra Medical manufactures its DABRA and Pharos excimer lasers and catheters in its approximately 32,000-square-foot facility located in Carlsbad, California. Ra Medical’s vertically integrated facility is ISO 13485 certified and is licensed by the state of California to manufacture sterile, single-use catheters in its controlled environments.

At the company:
Jeffrey Kraws, President
760-707-7516
jkraws@ramed.com

Investors:
LHA Investor Relations
Jody Cain / Kevin McCabe
310-691-7100
jcain@lhai.com / kmccabe@lhai.com

Media:
KCSA Strategic Communications
Caitlin Kasunich / Lisa Lipson
212-896-1241 / 508-843-6428
ckasunich@kcsa.com / llipson@kcsa.com

Source: Ra Medical Systems, Inc.